Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody

Por Ponte, Jose F, Ponath, Paul, Gulati, Reema, Slavonic, Michael, Paglia, Michael, O’Shea, Adam, Tone, Masahide, Waldmann, Herman, Vaickus, Louis, Rosenzweig, Michael
Publicado em 2010

Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models()...

Por Ponte, Jose F., Ab, Olga, Lanieri, Leanne, Lee, Jenny, Coccia, Jennifer, Bartle, Laura M., Themeles, Marian, Zhou, Yinghui, Pinkas, Jan, Ruiz-Soto, Rodrigo
Publicado no Neoplasia (2016)

Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate

Por Brand, Christian, Sadique, Ahmad, Houghton, Jacob L., Gangangari, Kishore, Ponte, Jose F., Lewis, Jason S., Pillarsetty, Naga Vara Kishore, Konner, Jason A., Reiner, Thomas
Publicado no EJNMMI Res (2018)

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models

Por Hicks, Stuart W., Lai, Katharine C., Gavrilescu, L. Cristina, Yi, Yong, Sikka, Surina, Shah, Prerak, Kelly, Meghan E., Lee, Jenny, Lanieri, Leanne, Ponte, Jose F., Sloss, Callum M., Romanelli, Angela
Publicado no Neoplasia (2017)

Phase 1 Dose-Escalation Study of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor α-Targeting Antibody-Drug Conjugate, in Patients With Solid Tumors

Por Moore, Kathleen N., Borghaei, Hossein, O’Malley, David M., Jeong, Woondong, Seward, Shelly M., Bauer, Todd M., Perez, Raymond P., Matulonis, Ursula A., Running, Kelli L., Zhang, Xiaoyan, Ponte, Jose F., Ruiz-Soto, Rodrigo, Birrer, Michael J.
Publicado no Cancer (2017)

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder

Por Abdolmaleky, Hamid Mostafavi, Cheng, Kuang-hung, Faraone, Stephen V., Wilcox, Marsha, Glatt, Stephen J., Gao, Fangming, Smith, Cassandra L., Shafa, Rahim, Aeali, Batol, Carnevale, Julie, Pan, Hongjie, Papageorgis, Panagiotis, Ponte, Jose F., Sivaraman, Vadivelu, Tsuang, Ming T., Thiagalingam, Sam
Publicado em 2006

Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody–Drug Conjugates (ADCs)

Por Archer, Katie E., Reid, Emily E., Shizuka, Manami, Woods, James, Harris, Luke, Maloney, Erin K., Bartle, Laura M., Ab, Olga, Wilhelm, Alan, Setiady, Yulius, Ponte, Jose F., Singh, Rajeeva, Keating, Thomas A., Chari, Ravi V. J., Miller, Michael L.
Publicado no ACS Med Chem Lett (2019)

Peptide-Cleavable Self-immolative Maytansinoid Antibody–Drug Conjugates Designed To Provide Improved Bystander Killing

Por Costoplus, Juliet A., Veale, Karen H., Qiu, Qifeng, Ponte, Jose F., Lanieri, Leanne, Setiady, Yulius, Dong, Ling, Skaletskaya, Anna, Bartle, Laura M., Salomon, Paulin, Wu, Rui, Maloney, Erin K., Kovtun, Yelena V., Ab, Olga, Lai, Kate, Chari, Ravi V. J., Widdison, Wayne C.
Publicado no ACS Med Chem Lett (2019)

In vitro and in vivo activity of IMGN853, an Antibody-Drug Conjugate targeting Folate Receptor Alpha linked to DM4, in biologically aggressive endometrial cancers

Por Altwerger, Gary, Bonazzoli, Elena, Bellone, Stefania, Egawa-Takata, Tomomi, Menderes, Gulden, Pettinella, Francesca, Bianchi, Anna, Riccio, Francesco, Feinberg, Jacqueline, Zammataro, Luca, Han, Chanhee, Yadav, Ghanshyam, Dugan, Katherine, Morneault, Ashley, Ponte, Jose F., Buza, Natalia, Hui, Pei, Wong, Serena, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., Santin, Alessandro D.
Publicado no Mol Cancer Ther (2018)